AIDS.GOV | SERVICE LOCATOR | SEARCH

BLOG.AIDS.GOV

MENU

NIH

NIDA 2014 Avant-Garde Award for HIV/AIDS Research

NIDA arp

This week, the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, announced the 2014 Avant-Garde Awards for HIV/AIDS research. According to a NIDA press release, the awards offer hope in battling HIV infection and improving long-term outcomes in HIV-infected drug users. With proposals ranging from enhancing the immune system’s ability…

Updated Guidelines: Perinatal Antiretroviral Treatment

AIDS info logo

The HHS Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission announces the release of the updated Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States. For a complete preview of key updates to the guidelines, please see What’s…

NIH’s Dr. Carl Dieffenbach Shares Highlights from CROI 2014 – March 5

Ron Valdiserri and Carl Dieffenbach

At the conclusion of sessions yesterday, March 5, at the 2014 Conference on Retroviruses and Opportunistic Infections (CROI) in Boston, NIH’s Dr. Carl Dieffenbach sat down with Dr. Ron Valdiserri to discuss some of the day’s scientific highlights. In their video conversation below, Dr. Dieffenbach observes that three significant advances in HIV therapies were among…

PrEP Topics Examined at CROI 2014

Ronald Valdiserri

Among the many issues being discussed by the scientists, providers, and advocates gathered at the 2014 Conference on Retroviruses and Opportunistic Infections (CROI)  in Boston this week is pre-exposure prophylaxis (PrEP) for HIV. In a number of clinical trials, daily oral PrEP has been proven to be an effective biomedical intervention for reducing the risk…

NIH Seeks Input on HIV Cure Research Priorities

nih logo

The National Institutes of Health (NIH) is asking the scientific community to weigh in on what should be the highest priority research areas related to understanding HIV persistence and investigating strategies for eradicating or controlling remaining virus despite optimal antiretroviral treatment. Responses will be accepted through March 14 and will help guide the HIV Cure Initiative, a $100 million…

Sharpening Our Focus on Black MSM Vital to Meeting National Goals

CDC Pie Chart

As we observe National Black HIV/AIDS Awareness Day (NBHAAD) 2014, we are reminded that African Americans face the most severe burden of HIV/AIDS in the United States. Among African Americans, gay, bisexual and other men who have sex with men (Black MSM) are especially hard hit, representing more than half of all estimated new HIV infections…

Scientists Discover Hepatitis C Virus Can Remain Infectious Outside of the Body for Up to 6 Weeks

Ronald Valdiserri

A recent study by researchers from the Yale Schools of Medicine and Public Health revealed that the hepatitis C virus (HCV) can remain infectious for up to 6 weeks on surfaces at room temperature—resulting in a much longer period for potential transmission than was previously appreciated.  Prior to this study, scientists believed that HCV could…

20 Years of Discovery: The Women’s Interagency HIV Study

facuci_160x160

Twenty years ago, when most HIV/AIDS patients were men, the National Institutes of Health (NIH) launched the Women’s Interagency HIV Study (WIHS), observing women in the United States who are either HIV-infected or at risk for becoming infected. Since then, results from the WIHS have informed unique aspects of care and treatment for HIV-infected women…

Page 2 of 91234...Last »